Comparative In silico Analysis of Hypertrophic Cardiomyopathy Heart in Human and Normal Chicken Heart by Karunanithi, Suganthi et al.
*Corresponding author:   E-mail: gtatbiotech@clri.res.in. 
www.sospublication.co.in      Journal of Advanced Laboratory Research in Biology 
                                                                                        






Comparative In silico Analysis of Hypertrophic Cardiomyopathy Heart in Human and 
Normal Chicken Heart 
 
Suganthi Karunanithi1, Lakshmanan Venkatachalapathy2, Yamini Sudhalakshmi3, Murugesan A.G.4  
and Thiyagarajan G.5* 
 
1,4Sri Paramakalyani Centre for Environmental Sciences, Manonmaniam Sundaranar University,  
Alwarkurichi-627 412, Tirunelveli, Tamil Nadu, India. 
2Department of Cardio-Thoracic Surgery, MMC, Chennai-632003, Tamil Nadu, India. 
3Department of Basic Health Sciences, Asmara College of Health Sciences, Asmara, Eritrea, Africa. 
5*Department of Biotechnology, Central Leather Research Institute, Adyar, Chennai-600 020, Tamil Nadu, India. 
 
 
Abstract: Hypertrophic Cardiomyopathy (HCM) is an incurable disease, which causes excessive thickening of the 
myocardium. HCM is caused by abnormalities in genes which code for the proteins responsible for contraction of 
the heart. The anatomical resemblances between the Chicken heart and HCM heart are thickening of the muscle of 
the left ventricle, localized ring- like thickening of muscle under the aortic valve, and poorly formed anterior 
ventricular groove, and left ventricle projecting beyond the right ventricle. The mutations for the genes are retrieved 
from the databases: Human Genome Mutation Database, Familial Hypertrophic Mutation Database and 
Cardiogenomics databases. Since the Beta-myosin Heavy Chain (MYH7) is more predominant in causing HCM, 
that gene alone is taken and compared with normal chicken heart myh7 gene. The amino acids were aligned by 
CLUSTAL W and they were found to have sequence homology of 85%. The phylogenetic tree was constructed by 
using PHYLIP to study evolutionary linkage. According to the results, it can be presumed that the chicken normal 
gene, during the evolutionary process have undergone many modifications and evolved as a complicated and 
advanced human heart. 
 




Birth defects are defined as abnormalities of 
structure, function and metabolism of the body that are 
evolved at birth. These abnormalities lead to mental or 
physical disabilities or even fatal [1, 2]. In fact, 
according to the March of Dimes, about 60% of birth 
defects have unknown causes [3]. The known factors 
are caused by environment or genetic factors or a 
combination of the two. In particular, congenital heart 
defects are the most found birth defects generally [4]. 
There are different types of congenital heart 
malformations; one of the most common diseases is 
Hypertrophic Cardiomyopathy (HCM). The HCM heart 
is characterized as thickening of the left ventricle 
muscle, localized ring like thickening of muscle under 
the aortic valve poorly formed anterior ventricular 
Chicken heart. In HCM, the muscle thickening occurs 
without an obvious cause. The thickened muscle 
usually contracts well and ejects most of the blood from 
the heart through the muscle in HCM is often stiff but 
relaxes poorly requiring higher pressures than normal 
inflow of blood to expand. The amount of blood which 
the heart can hold is therefore reduced and this, in turn, 
will limit the amount of blood which can be ejected 
with the next contraction [5, 6]. In addition, 
microdissection of the heart muscle with HCM shows 
that it has an abnormal arrangement of contractile 
filaments and the normal alignment of muscle cells is 
absent and this abnormality is called myocardial 
disarray. In the majority of cases, the condition is 
inherited [7-11]. It was found that totally 26 genes were 
involved in this disease. Myosin Heavy chain (MYH7) 
is the most predominant genes found mutated in the 
HCM patients [12]. 
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2. Materials and Methods 
 
The nucleotides of complete coding sequences of 
the genes causing the HCM disease were obtained from 
the National Center for Biological Information (NCBI) 
and the amino acid sequences were obtained from the 
SwissProt protein database 
(http://www.expasy.org/sprot/). For structure analysis 
of myh7 protein, structural sequences and their details 
were obtained from mod base databases. Since myh7 
has been more predominant in causing HCM, that gene 
alone has taken and analyzed for both chicken and 
human from the ENSEMBL Genome Browser. The 
chicken myh7 gene ENSEMBL Accession no. is 
ENSGALG00000013781 and the human gene 
Accession no. is ENSG00000092054. The mutations 
for the gene myh7 are retrieved from the Human 
Genome Mutation Database (HGMD), Familial 
Hypertrophic Cardiomyopathy Mutation Database 
(FHCMD) and Cardio genomics database. The normal 
and the mutated amino acid sequences of human myh7 
and the normal myh7 chicken gene were aligned using 
clustalW multiple sequence alignment tool. A 
phylogenetic tree is a specific type of cladogram where 
the branch lengths are proportional to the predicted or 
hypothetical evolutionary time between organisms or 
sequences [13]. These phylogenetic trees were 
constructed by using the software PHYLIP. 
 
3. Results  
 
3.1 Alignment results 
The normal and the mutated amino acid sequence 
of the myh7 in human and the normal sequence of the 
chicken were taken and aligned using ClustalW. The 
alignment results showed maximum conserved regions 
except for a few nucleotides which meant that the 
mutated gene of the Human is highly similar to the 






                                                  
Fig. 1. Alignment results of normal myh7 protein sequences of Human and chicken with mutated myh7 Protein. 
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Fig. 3. Unrooted Phylogenetic tree. 
 
3.2 Graphical Phylogenetic Tree 
Phylogenetic trees were constructed using the 
Phylip online software package for both amino acid 
sequences of myh7 protein of human and chicken. From 
the phylogenetic trees, it can be understood that the 
normal chicken myh7 gene has sequence similarity and 
an evolutionary linkage with mutated Human myh7 




According to the results, it can be inferred that 
normal chicken gene has undergone many 
modifications during evolution and evolved as a 
complicated and advanced human heart. Probably 
HCM-like condition might be an evolutionary defect, in 
cases like the myh7 gene in some individuals has not 
completely evolved to support our body need and hence 
appear diseased. We have studied only a single gene, 
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the myh7 but there are 25 genes more responsible for 
this HCM prevalence. Hence further study is needed to 
support the proposed theory. The important impact of 
this study is that the elaborate studies of evolutionary 
changes in the heart structure and function can give a 
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